Biotanic Lifesciences is an emerging, global pharmaceutical company with proven capabilities in the areas of product research, manufacturing & marketing. Over the years, Biotanic Lifesciences has emerged as one of the fastest growing Indian pharmaceutical companies. Our focus on specialty segments in India and simultaneous opening of newer markets abroad has helped us maintain the growth. We are firmly establishing our brands in each market for sustained sales. Biotanic Lifesciences has established strong capabilities in the international market with exports contributing a substantial part of the total revenues. Biotanic Lifesciences was incorporated in .... and has since moved up the value chain from being a small manufacturer to a vibrant marketing and research-oriented company. Biotanic Lifesciences is now one of the leading pharmaceutical companies from India.
Our Products Portfolio includes a wide range of therapeutic products covering segments like Anti-retrovirals, Anti-malarials, Cardiovascular, Dermatology and Ophthalmology among others. We also market OTC products. Our products also include some nature-based remedies.
Given our strong emphasis on product quality and service, Biotanic Lifesciences has been approved to supply medicines to various Government Institutions like Health Care Departments, Defence services and hospitals in India. Biotanic Lifesciences is also certified supplier to many big institutions and voluntary organizations like MSF and PSF, within and outside the country.
Biotanic Lifesciences is committed to develop new technologies. We have been able to launch products with enhanced release profiles to ensure better treatment compliance and dosage convenience.
A highly qualified and devoted workforce has always been an asset to the company. All the departments are interlinked to each other by a latest management co-ordination system to synchronize the administrative, manufacturing and marketing process of the company. With the support of its distributors and doctors, Aplomb Pharma is all set to achieve the goal of 100 million turn-over this year.
To become a leading global healthcare organization driven by people, research and technology
Contributing towards better healthcare through innovation. Maximizing value for our stakeholders and customers.